纤维化潜在的治疗药物:小分子化合物和天然产品
Yu Xiang1, Zhuo Yuan2, Qichuan Deng1
1Department of Pharmacy, Personalized Drug Therapy Key Laboratory of Sichuan Province, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, China.
纤维化是慢性病进展的关键因素,涉及细胞损伤和原沉积. 本综述探讨了治疗这种疾病的潜在治疗点和天然产品,旨在预防末期功能衰竭.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 病理学 病理学 病理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 纤维化是慢性病 (CKD) 中的一种渐进性病理过程.
- 它的特征是内在的细胞损伤,表型变化和过度的原沉积.
- 这导致膜硬化,功能受损,最终导致末期功能衰竭 (尿血).
研究的目的:
- 审查纤维化的诊断,病变和潜在的治疗抑制剂.
- 讨论潜在的治疗点及其抑制剂,包括药理效应和点相互作用.
- 总结一下对纤维化的潜在疗效的天然产品.
主要方法:
- 对纤维化现有研究的文献综述.
- 诊断标准和病原机制的分析.
- 对潜在治疗剂的药理学数据的探索.
主要成果:
- 纤维化是一个复杂的过程,由细胞损伤和矩阵积累驱动.
- 目前的治疗策略缺乏针对纤维化的具体点和药物.
- 几种潜在的标和天然产品显示出对治疗纤维化的前景.
结论:
- 对纤维化的有效治疗标和药物仍在开发中.
- 对药理抑制剂和天然产品的进一步研究至关重要.
- 本综述为对抗纤维化的未来治疗策略提供了见解.
更多相关视频
07:01Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models
Published on: May 10, 2022
04:37Unilateral Ureteral Obstruction Model for Investigating Kidney Interstitial Fibrosis
Published on: April 25, 2025
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Direct Renin Inhibitors
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Renal Drug Excretion: Tubular Secretion
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Heart Failure Drugs: Diuretics
